Clinical Trials List
2008-10-22 - 2010-10-22
Phase III
Terminated5
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- kang-Yun LEE Division of Thoracic Medicine
- Chun-Hua Wang Division of Thoracic Medicine
- Horng-Chyuan Lin Division of Thoracic Medicine
- Shu-Min Lin Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 邱國樑 Division of Thoracic Medicine
- 梁信杰 Division of Thoracic Medicine
- Te-Chun Hsia Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- CHIN-CHOU WANG Division of Thoracic Medicine
- 吳沼漧 Division of Thoracic Medicine
- 劉世豐 Division of Thoracic Medicine
- 林孟志 Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林旻希 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
510 participants
